The price of good health.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24710362.
- Also identified by DOI 10.1038/nm.3538.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efficacious new drugs to treat hepatitis C virus infection offer the potential to halt this epidemic. But their exorbitant cost may prove prohibitive for most patients in need. Strong patient and government advocacy will be necessary to ensure that accessibility to treatments is a right, not a privilege.
Medical subject headings
- Antiviral Agents
- Hepatitis C, Chronic